Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7763]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
Increasing access to quality assured and affordable essential medicines for...
Dr Yehoda Martei - Pennsylvania University, Pennsylvania, USA
Increasing access to quality assured and affordable essential medicines for cancer care in LMICs ( Dr Yehoda Martei - Pennsylvania University, Pennsylvania, USA )
23 Nov 2022
Fundamental discoveries for prostate cancer in Sub-Saharan Africa: The MADCaP...
Dr Timothy Rebbeck - Harvard University and Dana-Farber Cancer Institute...
Fundamental discoveries for prostate cancer in Sub-Saharan Africa: The MADCaP network ( Dr Timothy Rebbeck - Harvard University and Dana-Farber Cancer Institute, Boston, USA )
21 Nov 2022
Developing low cost therapies: Practical tips
Prof Ian Tannock - Princess Margaret Cancer Centre, Toronto, Canada
Developing low cost therapies: Practical tips ( Prof Ian Tannock - Princess Margaret Cancer Centre, Toronto, Canada )
27 Oct 2022
Complex technologies for advanced diagnosis and precision medicine in oncology
Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Complex technologies for advanced diagnosis and precision medicine in oncology ( Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
24 Oct 2022
Genomic testing in biliary tract cancers
Dr Chiara Braconi - University of Glasgow, Glasgow, UK
Genomic testing in biliary tract cancers ( Dr Chiara Braconi - University of Glasgow, Glasgow, UK )
24 Oct 2022
Molecular profiling in prostate cancer: key challenges for clinical...
Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Molecular profiling in prostate cancer: key challenges for clinical implementation ( Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
24 Oct 2022
Final OS analysis of ICARIA-MM: Isatuximab triplet shows continued survival...
Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA
Final OS analysis of ICARIA-MM: Isatuximab triplet shows continued survival benefit in R/R multiple myeloma ( Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA )
12 Oct 2022
ESMO 2022: Lung roundup
Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2022: Lung roundup ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
4 Oct 2022
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for...
Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN ( Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland )
27 Sep 2022
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
21 Sep 2022
Value based care with a focus on education
Dr Swarupa Mitra - Rajeev Gandhi Cancer Institute & Research Center, New Delhi...
Value based care with a focus on education ( Dr Swarupa Mitra - Rajeev Gandhi Cancer Institute & Research Center, New Delhi, India )
18 Sep 2022
ESMO 2022: Breast and ovarian trial analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Breast and ovarian trial analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
14 Sep 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation